English
Insider transactions
EDGARZymeworks Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 15 transactions, 256,798 shares
- Sum of shares × price per share: 6,448,804.7185
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 77
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 Filed 2026-11-18 | Platshon Scott Officer: EVP, Chief Business Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 37,037 | 0 | — | 37,037 | Direct (D) | No | F1
| Open filing 0001816539-26-000005 Read from the filing’s XML Dispute this row |
| 2026-11-18 Filed 2026-11-18 | Platshon Scott Officer: EVP, Chief Business Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 15,292 | 24.95 | 381,535.4Derived: shares × price per share. Exact value 381535.40. | 21,745 | Direct (D) | No | F2, F3
| Open filing 0001816539-26-000005 Read from the filing’s XML Dispute this row |
| 2026-11-18 Filed 2026-11-18 | Platshon Scott Officer: EVP, Chief Business Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 37,037 | 0 | — | 74,074 | Direct (D) | No | F4, F5
| Open filing 0001816539-26-000005 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Moore Paul Andrew Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 25,000 | 5.82 | 145,500Derived: shares × price per share. Exact value 145500.00. | 73,497 | Direct (D) | No | — | Open filing 0001938192-26-000007 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Moore Paul Andrew Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,367 | 26.14 | 192,573.38Derived: shares × price per share. Exact value 192573.38. | 66,130 | Direct (D) | No | F1
| Open filing 0001938192-26-000007 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Moore Paul Andrew Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,374 | 26.09 | 192,387.66Derived: shares × price per share. Exact value 192387.66. | 58,756 | Direct (D) | No | F2
| Open filing 0001938192-26-000007 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Moore Paul Andrew Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 25,000 | 26.04 | 651,000Derived: shares × price per share. Exact value 651000.00. | 33,756 | Direct (D) | No | F3
| Open filing 0001938192-26-000007 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Moore Paul Andrew Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 25,000 | 0 | — | 175,000 | Direct (D) | No | F4
| Open filing 0001938192-26-000007 Read from the filing’s XML Dispute this row |
| 2026-10-09 Filed 2026-10-09 | Schayowitz Adam Officer: EVP, Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 37,037 | 0 | — | 37,037 | Direct (D) | No | F1
| Open filing 0002127119-26-000006 Read from the filing’s XML Dispute this row |
| 2026-10-09 Filed 2026-10-09 | Schayowitz Adam Officer: EVP, Head of RD | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 13,832 | 25.85 | 357,557.2Derived: shares × price per share. Exact value 357557.20. | 23,205 | Direct (D) | No | F2, F3
| Open filing 0002127119-26-000006 Read from the filing’s XML Dispute this row |
| 2026-10-09 Filed 2026-10-09 | Schayowitz Adam Officer: EVP, Head of RD | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 37,037 | 0 | — | 74,074 | Direct (D) | No | F4, F5
| Open filing 0002127119-26-000006 Read from the filing’s XML Dispute this row |
| 2026-07-06 Filed 2026-07-06 | Hollywood Mark Officer: EVP Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 939 | 22.22 | 20,864.58Derived: shares × price per share. Exact value 20864.58. | 133,852 | Direct (D) | No | F1, F2
| Open filing 0002104446-26-000009 Read from the filing’s XML Dispute this row |
| 2026-05-13 Filed 2026-05-15 | Schneider Paul R Officer: EVP, General Counsel | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 178,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 178,000 | Direct (D) | No | F1
| Open filing 0001193125-26-227140 Read from the filing’s XML Dispute this row |
| 2026-05-13 Filed 2026-05-15 | Schneider Paul R Officer: EVP, General Counsel | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 119,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 119,000 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-227140 Read from the filing’s XML Dispute this row |
| 2026-04-09 Filed 2026-04-10 | Schayowitz Adam Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 70,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 70,000 | Direct (D) | No | F1
| Open filing 0001193125-26-151265 Read from the filing’s XML Dispute this row |
| 2026-04-09 Filed 2026-04-10 | Schayowitz Adam Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 47,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 47,000 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-151265 Read from the filing’s XML Dispute this row |
| 2026-04-09 Filed 2026-04-10 | Schayowitz Adam Officer: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 76,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 76,000 | Direct (D) | No | F4, F5
| Open filing 0001193125-26-151265 Read from the filing’s XML Dispute this row |
| 2026-04-09 Filed 2026-04-10 | Platshon Scott Officer: EVP, Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 70,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 70,000 | Direct (D) | No | F1
| Open filing 0001193125-26-151264 Read from the filing’s XML Dispute this row |
| 2026-04-09 Filed 2026-04-10 | Platshon Scott Officer: EVP, Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 47,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 47,000 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-151264 Read from the filing’s XML Dispute this row |
| 2026-04-09 Filed 2026-04-10 | Platshon Scott Officer: EVP, Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 76,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 76,000 | Direct (D) | No | F4, F5
| Open filing 0001193125-26-151264 Read from the filing’s XML Dispute this row |
| 2026-04-06 Filed 2026-04-07 | Stafford Kristin Officer: EVP, Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 178,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 178,000 | Direct (D) | No | F1
| Open filing 0001193125-26-145305 Read from the filing’s XML Dispute this row |
| 2026-04-06 Filed 2026-04-07 | Stafford Kristin Officer: EVP, Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 119,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 119,000 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-145305 Read from the filing’s XML Dispute this row |
| 2026-04-06 Filed 2026-04-07 | Stafford Kristin Officer: EVP, Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 50,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 50,000 | Direct (D) | No | F2, F4
| Open filing 0001193125-26-145305 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-13 | Hollywood Mark Officer: EVP Chief Operating Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 17,666 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 139,033 | Direct (D) | No | F1
| Open filing 0001193125-26-011885 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-13 | Hollywood Mark Officer: EVP Chief Operating Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,120 | 22.6735 | 138,761.82Derived: shares × price per share. Exact value 138761.8200. | 132,913 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-011885 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-13 | Hollywood Mark Officer: EVP Chief Operating Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 17,666 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 35,334 | Direct (D) | No | F4, F5
| Open filing 0001193125-26-011885 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-13 | Hollywood Mark Officer: EVP Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 70,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 70,000 | Direct (D) | No | F6
| Open filing 0001193125-26-011885 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-13 | Hollywood Mark Officer: EVP Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 47,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 47,000 | Direct (D) | No | F4, F7
| Open filing 0001193125-26-011885 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-13 | Hollywood Mark Officer: EVP Chief Operating Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 66,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 66,000 | Direct (D) | No | F8, F9
| Open filing 0001193125-26-011885 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-13 | Cherry Brian N Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 23,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 23,000 | Direct (D) | No | F1
| Open filing 0001193125-26-011793 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-13 | Cherry Brian N Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 15,400 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 15,400 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-011793 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Cesano Alessandra Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 11,500 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 11,500 | Direct (D) | No | F1
| Open filing 0001193125-26-010856 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Cesano Alessandra Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 7,700 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 7,700 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-010856 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Ciongoli Gregory Austin Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 11,500 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 11,500 | Direct (D) | No | F1
| Open filing 0001193125-26-010864 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Ciongoli Gregory Austin Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 7,700 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 7,700 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-010864 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Mahony Susan Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 11,500 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 11,500 | Direct (D) | No | F1
| Open filing 0001193125-26-010843 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Mahony Susan Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 7,700 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 7,700 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-010843 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Galbraith Kenneth Director · Officer: Chair CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 64,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 257,266 | Direct (D) | No | F1
| Open filing 0001193125-26-010790 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Galbraith Kenneth Director · Officer: Chair CEO | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 30,424 | 22.6735 | 689,818.564Derived: shares × price per share. Exact value 689818.5640. | 226,842 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-010790 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Galbraith Kenneth Director · Officer: Chair CEO | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 64,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 128,000 | Direct (D) | No | F4, F5
| Open filing 0001193125-26-010790 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Galbraith Kenneth Director · Officer: Chair CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 216,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 216,000 | Direct (D) | No | F6
| Open filing 0001193125-26-010790 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Galbraith Kenneth Director · Officer: Chair CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 144,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 144,000 | Direct (D) | No | F4, F7
| Open filing 0001193125-26-010790 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Galbraith Kenneth Director · Officer: Chair CEO | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 222,000 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 222,000 | Direct (D) | No | F8, F9
| Open filing 0001193125-26-010790 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Campoy Carlos Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 11,500 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 11,500 | Direct (D) | No | F1
| Open filing 0001193125-26-010852 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Campoy Carlos Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 7,700 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 7,700 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-010852 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Smith Jeffrey T L Officer: EVP Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 17,666 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 36,018 | Direct (D) | No | F1
| Open filing 0001193125-26-010865 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Smith Jeffrey T L Officer: EVP Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,310 | 22.6735 | 211,090.285Derived: shares × price per share. Exact value 211090.2850. | 26,708 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-010865 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Smith Jeffrey T L Officer: EVP Chief Medical Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 17,666 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 35,334 | Direct (D) | No | F4, F5
| Open filing 0001193125-26-010865 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Moore Paul Andrew Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 17,666 | 0.00 | 0Derived: shares × price per share. Exact value 0.00. | 58,057 | Direct (D) | No | F1
| Open filing 0001193125-26-010834 Read from the filing’s XML Dispute this row |
| 2026-01-12 Filed 2026-01-12 | Moore Paul Andrew Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,560 | 22.6735 | 216,758.66Derived: shares × price per share. Exact value 216758.6600. | 48,497 | Direct (D) | No | F2, F3
| Open filing 0001193125-26-010834 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–50 of 215
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| EcoR1 Capital, LLC | 22,970,388 SH | 608,485,578 dollars | Unchanged Prior quarter: 22,970,388 | Open filing 0000935836-26-000577 Filed 2026-11-16 Dispute this row |
| Rubric Capital Management LP | 7,000,000 SH | 185,430,000 dollars | Unchanged Prior quarter: 7,000,000 | Open filing 0001104659-26-128244 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 4,212,745 SH | 111,595,615 dollars | Lower by 38,285 Prior quarter: 4,251,030 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| PERCEPTIVE ADVISORS LLC | 3,545,501 SH | 93,920,321 dollars | Lower by 637,452 Prior quarter: 4,182,953 | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| BVF INC/IL Partly reported under another manager | 3,464,142 SH | 91,765,122 dollars | Lower by 185,000 Prior quarter: 3,649,142 | Open filing 0000921895-26-003162 Filed 2026-11-16 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 3,236,915 SH | 85,745,882 dollars | Higher by 1,005,655 Prior quarter: 2,231,260 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. Partly reported under another manager | 1,781,031 SH | 47,179,511 dollars | Lower by 85 Prior quarter: 1,781,116 | Open filing 0001520354-26-000046 Filed 2026-11-13 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,558,998 SH | 41,297,857 dollars | Unchanged Prior quarter: 1,558,998 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| Assenagon Asset Management S.A. | 1,508,069 SH | 39,948,748 dollars | Lower by 995,985 Prior quarter: 2,504,054 | Open filing 0001546007-26-000008 Filed 2026-10-15 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 1,192,391 SH | 31,586,438 dollars | Higher by 278,255 Prior quarter: 914,136 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Nextech Invest Ltd. | 1,113,946 SH | 29,508,430 dollars | Unchanged Prior quarter: 1,113,946 | Open filing 0001595430-26-000015 Filed 2026-11-16 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 1,094,008 SH | 28,980,272 dollars | Higher by 5,792 Prior quarter: 1,088,216 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 954,409 SH | 25,282,295 dollars | Higher by 483,587 Prior quarter: 470,822 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. Partly reported under another manager | 874,776 SH | 23,172,816 dollars | Lower by 15,026 Prior quarter: 889,802 | Open filing 0000905148-26-004861 Filed 2026-11-16 Dispute this row |
| Prosight Management, LP | 721,100 SH | 19,101,939 dollars | Higher by 46,666 Prior quarter: 674,434 | Open filing 0001420506-26-002713 Filed 2026-11-13 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 684,966 SH | 18,144,163 dollars | Lower by 7,444 Prior quarter: 692,410 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Fisher Asset Management, LLC Partly reported under another manager | 608,612 SH | 16,122,131 dollars | Higher by 537,837 Prior quarter: 70,775 | Open filing 0000850529-26-000009 Filed 2026-11-06 Dispute this row |
| Vestal Point Capital, LP | 600,000 SH | 15,894,000 dollars | Not in the prior quarter’s filings read | Open filing 0001974915-26-000008 Filed 2026-11-16 Dispute this row |
| DIMENSIONAL FUND ADVISORS LP Partly reported under another manager | 530,448 SH | 14,051,568 dollars | Lower by 464,507 Prior quarter: 994,955 | Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row |
| Redmile Group, LLC | 491,654 SH | 13,023,914 dollars | Unchanged Prior quarter: 491,654 | Open filing 0000905148-26-004923 Filed 2026-11-16 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 469,847 SH | 12,446,247 dollars | Lower by 40,185 Prior quarter: 510,032 | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 400,074 SH | 10,597,960 dollars | Not in the prior quarter’s filings read | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| DEUTSCHE BANK AG\ Partly reported under another manager | 390,842 SH | 10,353,404 dollars | Lower by 6,348 Prior quarter: 397,190 | Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row |
| Man Group plc Partly reported under another manager | 342,191 SH | 9,064,639 dollars | Higher by 131,412 Prior quarter: 210,779 | Open filing 0001637460-26-000004 Filed 2026-11-16 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 314,293 SH | 8,325,622 dollars | Lower by 6,780 Prior quarter: 321,073 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| Hillsdale Investment Management Inc. | 276,372 SH | 7,321,095 dollars | Lower by 106,550 Prior quarter: 382,922 | Open filing 0001193125-26-457091 Filed 2026-11-12 Dispute this row |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 276,038 SH | 7,312,247 dollars | Higher by 52,272 Prior quarter: 223,766 | Open filing 0001193125-26-462346 Filed 2026-11-16 Dispute this row |
| FEDERATED HERMES, INC. Partly reported under another manager | 246,979 SH | 6,542,474 dollars | Higher by 58,984 Prior quarter: 187,995 | Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row |
| D. E. Shaw Co., Inc. Partly reported under another manager | 233,441 SH | 6,183,852 dollars | Higher by 88,634 Prior quarter: 144,807 | Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row |
| Jump Financial, LLC Partly reported under another manager | 230,236 SH | 6,098,952 dollars | Higher by 204,628 Prior quarter: 25,608 | Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row |
| FMR LLC Partly reported under another manager | 230,164 SH | 6,097,050 dollars | Lower by 472,404 Prior quarter: 702,568 | Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row |
| WELLS FARGO COMPANY/MN Partly reported under another manager | 228,279 SH | 6,047,102 dollars | Higher by 11,080 Prior quarter: 217,199 | Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row |
| PICTON MAHONEY ASSET MANAGEMENT | 225,489 SH | 5,973,206 dollars | Lower by 45,854 Prior quarter: 271,343 | Open filing 0001539041-26-000039 Filed 2026-11-09 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 222,443 SH | 5,892,516 dollars | Higher by 3,372 Prior quarter: 219,071 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Granahan Investment Management, LLC | 219,649 SH | 5,818,502 dollars | Lower by 116,508 Prior quarter: 336,157 | Open filing 0001398344-26-020113 Filed 2026-11-16 Dispute this row |
| Pictet Asset Management Holding SA | 188,468 SH | 5,120,814 dollars | Lower by 119,719 Prior quarter: 308,187 | Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row |
| KENNEDY CAPITAL MANAGEMENT LLC | 177,151 SH | 4,692,730 dollars | Higher by 31,765 Prior quarter: 145,386 | Open filing 0000884589-26-000015 Filed 2026-11-13 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 169,778 SH | 5,252,931 dollars | Higher by 93,250 Prior quarter: 76,528 | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| Invesco Ltd. Partly reported under another manager | 169,585 SH | 4,492,307 dollars | Higher by 57,373 Prior quarter: 112,212 | Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row |
| HRT FINANCIAL LP | 167,514 SH | 4,437 dollars | Not in the prior quarter’s filings read | Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row |
| Campbell CO Investment Adviser LLC | 159,514 SH | 4,225,526 dollars | Higher by 98,640 Prior quarter: 60,874 | Open filing 0001140361-26-043564 Filed 2026-11-13 Dispute this row |
| RAYMOND JAMES FINANCIAL INC Partly reported under another manager | 151,259 SH | 4,006,850 dollars | Lower by 15,157 Prior quarter: 166,416 | Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 134,873 SH | 3,668,545 dollars | Higher by 28,475 Prior quarter: 106,398 | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 133,873 SH | 3,546,296 dollars | Higher by 61,999 Prior quarter: 71,874 | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| AQR CAPITAL MANAGEMENT LLC Partly reported under another manager | 130,337 SH | 3,452,628 dollars | Higher by 19,055 Prior quarter: 111,282 | Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row |
| UBS Group AG Partly reported under another manager | 129,171 SH | 3,421,740 dollars | Higher by 14,076 Prior quarter: 115,095 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Bank of New York Mellon Corp Partly reported under another manager | 128,828 SH | 3,412,645 dollars | Lower by 2,278 Prior quarter: 131,106 | Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row |
| MACKENZIE FINANCIAL CORP | 121,617 SH | 3,221,634 dollars | Higher by 33,872 Prior quarter: 87,745 | Open filing 0001062993-26-005652 Filed 2026-11-02 Dispute this row |
| LMR Partners LLP Partly reported under another manager | 120,000 SH | 3,178,800 dollars | Higher by 37,500 Prior quarter: 82,500 | Open filing 0001578621-26-000193 Filed 2026-11-16 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 119,032 SH | 3,153,158 dollars | Lower by 357 Prior quarter: 119,389 | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- Capricorn Fund Managers Ltd 486,529 SH
- SummitTX Capital, L.P. 210,802 SH
- Sixth Street Partners Management Company, L.P. 152,416 SH
- DIADEMA PARTNERS LP 142,132 SH
- PANAGORA ASSET MANAGEMENT INC 118,603 SH
- WELLINGTON MANAGEMENT GROUP LLP 110,014 SH
- PRINCIPAL FINANCIAL GROUP INC 84,990 SH
- TUDOR INVESTMENT CORP ET AL 36,471 SH
- Persistent Asset Partners Ltd 35,935 SH
- STRS OHIO 26,500 SH
- Brevan Howard Capital Management LP 25,956 SH
- Jupiter Topco LLC 18,200 SH
- JANE STREET GROUP, LLC 17,437 SH
- HSBC HOLDINGS PLC 15,588 SH
- INTECH INVESTMENT MANAGEMENT LLC 11,935 SH
- PSP Research LLC 10,000 SH
- Allspring Global Investments Holdings, LLC 8,762 SH
- INCEPTIONR LLC 8,313 SH
- Magnetar Financial LLC 8,292 SH
- SG Americas Securities, LLC 6,321 SH
- MERCER GLOBAL ADVISORS INC /ADV 3,893 SH
- DekaBank Deutsche Girozentrale 3,843 SH
- Asset Management One Co., Ltd. 1,659 SH
- Eurizon Capital SGR S.p.A. 1,321 SH
- Caitong International Asset Management Co., Ltd 1,309 SH
- Freestone Grove Partners LP 648 SH
- Inspire Investing, LLC 332 SH
- Integrated Wealth Concepts LLC 295 SH
- Quarry LP 210 SH
- Kilter Group LLC 66 SH
- INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 25 SH
- Clearstead Advisors, LLC 6 SH
- Silver Grove Financial Group, Inc. 4 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Perceptive Advisors LLC Common Stock, $0.00001 par value per share | 5.4 | 3,974,579 | 04/08/2026 Filed 2026-04-15 | SCHEDULE 13G | Open filing 0001193125-26-157043 Dispute this row |
| Joseph Edelman Common Stock, $0.00001 par value per share | 5.4 | 3,974,579 | 04/08/2026 Filed 2026-04-15 | SCHEDULE 13G | Open filing 0001193125-26-157043 Dispute this row |
| Perceptive Life Sciences Master Fund, Ltd. Common Stock, $0.00001 par value per share | 5.4 | 3,974,579 | 04/08/2026 Filed 2026-04-15 | SCHEDULE 13G | Open filing 0001193125-26-157043 Dispute this row |
| Rubric Capital Management LP Common Stock, $0.00001 par value per share | 9.49 | 7,000,000.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-26-062529 Dispute this row |
| David Rosen Common Stock, $0.00001 par value per share | 9.49 | 7,000,000.00 | 03/31/2026 Filed 2026-05-15 | SCHEDULE 13G/AAmendment 2 | Open filing 0001104659-26-062529 Dispute this row |
| Rubric Capital Management LP Common Stock, $0.00001 par value per share | 7.68 | 5,750,000.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-015252 Dispute this row |
| David Rosen Common Stock, $0.00001 par value per share | 7.68 | 5,750,000.00 | 12/31/2025 Filed 2026-02-13 | SCHEDULE 13G/AAmendment 1 | Open filing 0001104659-26-015252 Dispute this row |
| Morgan Stanley Common Stock | 3.4 | 2,519,243 | 12/31/2025 Filed 2026-02-12 | SCHEDULE 13G/AAmendment 3 | Open filing 0000895421-26-000053 Dispute this row |
| EcoR1 Capital, LLC Common Stock | 30.7 | 22,970,388.00 | 11/16/2025 Filed 2025-11-19 | SCHEDULE 13D/AAmendment 7 | Open filing 0000935836-25-000711 Dispute this row |
| Oleg Nodelman Common Stock | 30.7 | 22,970,388.00 | 11/16/2025 Filed 2025-11-19 | SCHEDULE 13D/AAmendment 7 | Open filing 0000935836-25-000711 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 28.8 | 21,582,563.00 | 11/16/2025 Filed 2025-11-19 | SCHEDULE 13D/AAmendment 7 | Open filing 0000935836-25-000711 Dispute this row |
| Redmile Group, LLC Common Stock, par value $0.00001 per share | 4.9 | 3,705,750.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 6 | Open filing 0001104659-25-112552 Dispute this row |
| Jeremy C. Green Common Stock, par value $0.00001 per share | 4.9 | 3,705,750.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 6 | Open filing 0001104659-25-112552 Dispute this row |
| BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.00001 par value per share | 2.7 | 2,045,162.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| BVF I GP LLC Common Stock, $0.00001 par value per share | 2.7 | 2,045,162.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.00001 par value per share | 2.1 | 1,601,489.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| BVF II GP LLC Common Stock, $0.00001 par value per share | 2.1 | 1,601,489.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| Biotechnology Value Trading Fund OS LP Common Stock, $0.00001 par value per share | 0.3 | 212,898.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| BVF Partners OS Ltd. Common Stock, $0.00001 par value per share | 0.3 | 212,898.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| BVF GP HOLDINGS LLC Common Stock, $0.00001 par value per share | 4.9 | 3,646,651.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| BVF PARTNERS L P/IL Common Stock, $0.00001 par value per share | 5.2 | 3,938,641.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| BVF INC/IL Common Stock, $0.00001 par value per share | 5.2 | 3,938,641.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| LAMPERT MARK N Common Stock, $0.00001 par value per share | 5.2 | 3,938,641.00 | 09/30/2025 Filed 2025-11-14 | SCHEDULE 13G/AAmendment 2 | Open filing 0000921895-25-003117 Dispute this row |
| Redmile Group, LLC Common Stock, par value $0.00001 per share | 5.6 | 4,150,627.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 5 | Open filing 0001104659-25-078645 Dispute this row |
| Jeremy C. Green Common Stock, par value $0.00001 per share | 5.6 | 4,150,627.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 5 | Open filing 0001104659-25-078645 Dispute this row |
| Redmile Biopharma Investments III, L.P. Common Stock, par value $0.00001 per share | 4.6 | 3,470,727.00 | 06/30/2025 Filed 2025-08-14 | SCHEDULE 13G/AAmendment 5 | Open filing 0001104659-25-078645 Dispute this row |
| BlackRock, Inc. Common Stock | 4.8 | 3,559,828 | 06/30/2025 Filed 2025-07-16 | SCHEDULE 13G/AAmendment 1 | Open filing 0002052113-25-002527 Dispute this row |
| EcoR1 Capital, LLC Common Stock | 30.7 | 22,970,388.00 | 06/26/2025 Filed 2025-06-27 | SCHEDULE 13D | Open filing 0000935836-25-000439 Dispute this row |
| Oleg Nodelman Common Stock | 30.7 | 22,970,388.00 | 06/26/2025 Filed 2025-06-27 | SCHEDULE 13D | Open filing 0000935836-25-000439 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 28.8 | 21,582,563.00 | 06/26/2025 Filed 2025-06-27 | SCHEDULE 13D | Open filing 0000935836-25-000439 Dispute this row |
| EcoR1 Capital, LLC Common Stock | 21.3 | 14,692,281.00 | 12/19/2024 Filed 2024-12-23 | SCHEDULE 13D/AAmendment 1 | Open filing 0000935836-24-000776 Dispute this row |
| Oleg Nodelman Common Stock | 21.3 | 14,692,281.00 | 12/19/2024 Filed 2024-12-23 | SCHEDULE 13D/AAmendment 1 | Open filing 0000935836-24-000776 Dispute this row |
| EcoR1 Capital Fund Qualified, L.P. Common Stock | 20.1 | 13,839,128.00 | 12/19/2024 Filed 2024-12-23 | SCHEDULE 13D/AAmendment 1 | Open filing 0000935836-24-000776 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,671,519 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 88,606 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,123 |
Filings made before the SEC required XML are listed, not extracted.